EMD-27920

Single-particle
2.7 Å
EMD-27920 Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27920

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8e6j summary report (pdf.gz) Map-8e6j FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

3H03 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)

EMD-27920

Single-particle
2.7 Å
EMD-27920 Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus (A/Brevig Mission/1/1918(H1N1)), Homo sapiens
Sample: 3H03 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)
Fitted models: 8e6j

Deposition Authors: Turner HL, Ozorowski G, Ward AB
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
PUBMED: 37506693
DOI: doi:10.1016/j.immuni.2023.07.004
ISSN: 1074-7613
ASTM: IUNIEH